arrow
G

Gagandeep Singh

Icahn School of Medicine at Mount Sinai
H指数:15
被引数:1,734

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sustained superior humoral immune responses of mRNA vaccines compared to Sputnik V viral vector COVID-19 vaccines in naïve and convalescent populations

与Sputnik V病毒载体COVID-19疫苗相比,mRNA疫苗在健康人群和康复人群中表现出持续更优的体液免疫应答。

Vaccine
IF3.5
2025-12-020
OAAI
Pathogenicity and transmissibility of bovine-derived HPAI H5N1 B3.13 virus in pigs

牛源HPAI H5N1 B3.13病毒在猪中的致病性和传播性

2025-06-160
OA
Injectable Estradiol Use in Transgender and Gender-Diverse Individuals throughout the United States
2025-01-111
OA
A Surrogate Enzyme-Linked Immunosorbent Assay to Select High-Titer Human Convalescent Plasma for Treating Immunocompromised Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern
2025-01-030
PRE
H5N1 clade 2.3.4.4b dynamics in experimentally infected calves and cows
Nature
IF48.5
2024-09-250
OAAI
Plitidepsin as an Immunomodulator against Respiratory Viral Infections

Plitidepsin作为抗呼吸道病毒感染的免疫调节剂

2024-02-280
PRE
Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity
MBIO
IF4.7
2024-02-142
OAAI
Experimental co-infection of calves with SARS-CoV-2 Delta and Omicron variants of concern

犊牛与SARS-CoV-2三角洲和Omicron变体的实验性共感染

2023-12-303
OAAI
Fungal microbiota sustains lasting immune activation of neutrophils and their progenitors in severe COVID-19
2023-10-2326
OA
Lipid Nanoparticle Encapsulation Empowers Poly(I:C) to Activate Cytoplasmic RLRs and Thereby Increases Its Adjuvanticity
SMALL
IF12.1
2023-10-229
OA
Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice

多组分鼻内佐剂用于年轻和老年小鼠的粘膜和持久全身SARS-CoV-2免疫

2023-06-296
OAAI
SARS-CoV-2 Ancestral and Variant of Concern Breakthrough infections boost both cross-reactive cellular and humoral immune responses in mRNA-vaccinated Hamsters.
2023-05-010
OA
Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants
MED
IF11.8
2022-10-018
OAAI
Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera
2022-07-0723
OAAI
Virus-induced senescence is a driver and therapeutic target in COVID-19
Nature
IF48.5
2021-09-130
PRE